1. A case of Epstein-Barr virus-positive mucocutaneous ulcer in the right tongue that disappeared after treatment for oral candidiasis
- Author
-
Tomoyo Nozato, Mikio Ozawa, Kenji Mitsudo, Tomomichi Ozawa, Makoto Hirota, and Kohei Osawa
- Subjects
medicine.medical_specialty ,CD30 ,medicine.diagnostic_test ,business.industry ,Mucocutaneous zone ,Vitiligo ,medicine.disease ,Dermatology ,Pathology and Forensic Medicine ,Discontinuation ,medicine.anatomical_structure ,Otorhinolaryngology ,Tongue ,hemic and lymphatic diseases ,Rheumatoid arthritis ,Biopsy ,medicine ,Surgery ,Methotrexate ,Oral Surgery ,business ,medicine.drug - Abstract
The present report describes a case of Epstein-Barr virus (EBV)-positive mucocutaneous ulcer (EBVMCU) with an ulcerative lesion on the right tongue. A 69-year-old Japanese woman with awareness of pain in the right lingual margin visited our hospital. The patient had rheumatoid arthritis and had been treated with methotrexate (MTX) for 9 years. Vitiligo was found throughout the oral cavity, and ulceration was found on the right tongue. Under a diagnosis of oral candidiasis and suspected right tongue tumor, treatment for candidiasis and biopsy of the right tongue ulcer were performed. Histopathological results were positive for CD20 and CD30 and negative for CD3 and CD5. EBV-encoded small RNA in situ hybridization confirmed positive results in large, atypical cells, suggesting involvement of EBV. EBVMCU was diagnosed based on the history of MTX use associated with rheumatoid arthritis, blood biochemical findings, and histopathological findings. The ulcer on the right tongue margin resolved spontaneously after treatment for oral candidiasis prior to discontinuation of MTX. No recurrence was seen for 18 months.
- Published
- 2022
- Full Text
- View/download PDF